HilleVax, Inc.
HilleVax, Inc. (HLVX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HLVX · as of Jun 9, 2026
Key Statistics
Explore HilleVax, Inc. Data
hlvx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 16.7%
The HLVX analyst consensus is Hold, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $32.00, representing +1431.10% upside from the current price of $2.09.
Competitors & Peers
hlvx competitorsHLVX
AADI
BLI
CYT
DBTX
IMDXStock Performance
Full HistoryAbout HilleVax, Inc.
HilleVax, Inc. is a clinical-stage biopharmaceutical enterprise specializing in the creation and market introduction of innovative vaccines. The company's lead investigational product is HIL-214, a va…
what is hillevax, inc. · hlvx stock overview · hillevax, inc. company profile · who is hillevax, inc. ceo · hlvx NASDAQ · hillevax, inc. headquarters · hillevax, inc. business segments
About Stock Overview & Key Data
HilleVax, Inc. (HLVX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 29, 2022. As of the latest trading session, HLVX stock price is $2.09, with a market capitalization of $104.8M. The stock has returned +11.76% over the past 12 months and +0.48% year-to-date.
According to 6 Wall Street analysts, the consensus rating for HilleVax, Inc. stock is Hold, with an average 12-month price target of $32.00. In fiscal year 2024, HilleVax, Inc. reported revenue of — and net income of -$147.3M. For detailed data — including HilleVax, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, HilleVax, Inc. (HLVX) stock price is $2.09. The stock is traded on NASDAQ under the ticker symbol HLVX. The 52-week range is $1.34 – $2.17.